1. Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential
   Lindsay R. Dresang et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
2. Obesity and colorectal cancer: molecular features of adipose tissue
   Javier Martinez-Useros et al, 2016, Journal of Translational Medicine CrossRef
3. The Anticancer Potential of Peroxisome Proliferator‐Activated Receptor Antagonists
   Laura De Lellis et al, 2018, ChemMedChem CrossRef
4. Colorectal cancer and obesity
   Brian E. Walkowski et al, 2023, The Link Between Obesity and Cancer CrossRef
5. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH
   Fang Guo et al, 2016, Gene CrossRef
6. In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
   Karin J. Stebbins et al, 2017, European Journal of Pharmacology CrossRef
7. Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies
   Jason D. Jacintho et al, 2019, Bioorganic & Medicinal Chemistry Letters CrossRef
8. PPARG expression in colorectal cancer and its association with staging and clinical evolution
   Andre Luiz Prezotto Villa et al, 2020, Acta Cirúrgica Brasileira CrossRef
9. Activation and Expression of Peroxisome Proliferator-Activated Receptor Alpha Are Associated with Tumorigenesis in Colorectal Carcinoma
   Tatsuya Morinishi et al, 2019, PPAR Research CrossRef